2026 Q2 Portfolio Activity
In 2026 Q2, Foresite Capital Management VI LLC maintained a portfolio of 25 distinct positions. The most significant new addition was Seaport Therapeutics, Inc., now representing 6.02% of the total fund value. They heavily accumulated shares in GH Research PLC, increasing the position by 198.1%. Conversely, Foresite Capital Management VI LLC completely exited their position in Centessa Pharmaceuticals plc.
Position History
hover any row below to update
Loading…
Total Positions
25
Quarter
2026 Q2
Top Holding
CGON (26.2%)
Top 10 Concentration
81.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-25 of 25
Foresite Capital Management VI LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CGON
CG Oncology, In...
|
Healthcare | 26.20% | 32.67% |
#1
Prev: #1
|
8.0 |
—
|
148,100 | 6.7% |
P
S
|
2,369,574 | $168,358,233 |
$31.33
+137.3%
|
2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ALMS
ALUMIS INC.
|
Healthcare | 18.60% | 20.33% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
4,247,670 | $119,529,434 |
$7.81
+197.2%
|
2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
N/A
Seaport Therape...
|
|
Unknown | 6.02% | — |
#3
Prev: #—
|
6.9 |
—
|
1,779,521 | — |
NEW
|
1,779,521 | $38,651,196 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
DNLI
Denali Therapeu...
|
Healthcare | 5.59% | 5.05% |
#4
1
Prev: #5
|
4.7 |
—
|
186,800 | 15.4% |
P
S
|
1,396,771 | $35,924,950 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
Celldex Therape...
|
Healthcare | 5.09% | 2.18% |
#5
5
Prev: #10
|
5.5 |
—
|
563,800 | 178.5% |
P
S
|
879,713 | $32,734,121 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 4.53% | 3.86% |
#6
Prev: #6
|
4.3 |
—
|
260,000 | 49.5% |
P
S
|
785,000 | $29,131,350 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRVS
Corvus Pharmace...
|
Healthcare | 4.26% | 5.82% |
#7
3
Prev: #4
|
2.7 |
—
|
no change | no change |
P
S
|
1,831,233 | $27,358,621 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Parabilis Medic...
|
|
Unknown | 4.26% | — |
#8
Prev: #—
|
5.2 |
—
|
999,044 | — |
NEW
|
999,044 | $27,343,834 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
GHRS
GH Research PLC
|
Healthcare | 3.93% | 0.96% |
#9
7
Prev: #16
|
4.6 |
—
|
625,001 | 198.1% |
P
S
|
940,493 | $25,280,452 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 3.07% | 0.98% |
#10
5
Prev: #15
|
4.2 |
—
|
566,667 | 177.1% |
P
S
|
886,667 | $19,701,741 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HNGE
Hinge Health, I...
|
Healthcare | 2.85% | 1.85% |
#11
1
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
220,400 | $18,293,200 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KYMR
Kymera Therapeu...
|
Healthcare | 2.61% | 2.65% |
#12
4
Prev: #8
|
2.0 |
—
|
no change | no change |
P
S
|
146,332 | $16,779,890 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ATAI
AtaiBeckley Inc...
|
Healthcare | 2.26% | 2.12% |
#13
2
Prev: #11
|
1.9 |
—
|
no change | no change |
P
S
|
2,750,000 | $14,492,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
Verastem, Inc.
|
Healthcare | 1.87% | 3.62% |
#14
7
Prev: #7
|
1.7 |
—
|
no change | no change |
P
S
|
3,146,631 | $12,020,130 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BEAM
Beam Therapeuti...
|
Healthcare | 1.76% | — |
#15
Prev: #—
|
4.2 |
—
|
330,000 | — |
NEW
|
330,000 | $11,325,600 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NERV
Minerva Neurosc...
|
Healthcare | 1.71% | 2.60% |
#16
7
Prev: #9
|
1.2 |
—
|
-1,016 | -0.1% |
P
S
|
1,985,584 | $11,019,991 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVBP
ArriVent BioPha...
|
Healthcare | 1.63% | — |
#17
Prev: #—
|
4.2 |
—
|
301,341 | — |
NEW
|
301,341 | $10,468,586 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AURA
Aura Bioscience...
|
Healthcare | 1.47% | — |
#18
Prev: #—
|
4.1 |
—
|
1,333,334 | — |
NEW
|
1,333,334 | $9,466,671 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
Crinetics Pharm...
|
Healthcare | 1.23% | 1.67% |
#19
6
Prev: #13
|
1.5 |
—
|
no change | no change |
P
S
|
212,010 | $7,933,414 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Research Allian...
|
|
Unknown | 0.50% | — |
#20
Prev: #—
|
3.7 |
—
|
300,000 | — |
NEW
|
300,000 | $3,210,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ZURA
Zura Bio Ltd
|
Healthcare | 0.41% | 0.58% |
#21
4
Prev: #17
|
1.2 |
—
|
no change | no change |
P
S
|
450,000 | $2,655,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Kailera Therape...
|
|
Unknown | 0.13% | — |
#22
Prev: #—
|
3.6 |
—
|
37,500 | — |
NEW
|
37,500 | $826,125 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
IRON
Disc Medicine, ...
|
Healthcare | 0.01% | — |
#23
Prev: #—
|
3.5 |
—
|
970 | — |
NEW
|
970 | $70,946 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OKUR
OnKure Therapeu...
|
Healthcare | 0.00% | 1.30% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-1,445,783 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNTA
Centessa Pharma...
|
Healthcare | 0.00% | 11.77% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-1,364,019 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-25 of 25 holdings